Each year, we highlight companies that received sizeable early-stage funding in the previous year. Wild Bioscience is pursuing crop gene editing for higher yields and climate resilience nature.com/articles/s4158…
Nature Biotechnology
Verified account This account is verified. Learn more@NatureBiotech
Publishing the best of biotech science and business. Find us on Bluesky, Facebook & Instagram. Part of @SpringerNature and @NaturePortfolio.
2.8K Following 326K Followers 18K Posts
Latest posts 5
Join pioneering researchers at RNA at the Bench and Bedside V on December 8-10, 2026. The conference will discuss the development of nucleic acid medicines including recent clinical successes, and current and upcoming challenges. Registration is available until November 10: go.nature.com/4vvBZDL
Scientists mining the ‘dark proteome’ are uncovering thousands of previously missed proteins, including promising new targets for cancer immunotherapies nature.com/articles/s4158…
rdcu.be/YxZrAghhPmsa
rdcu.be/YxZrAghhPmsa
Happy anniversary! Our October editorial celebrates 10 years of accomplishments and looks ahead to the future nature.com/articles/s4158…
www.nature.com Ten years, tens of millions of cells Nature Biotechnology - As the Human Cell Atlas project enters its second decade, the question is no longer whether we can map human cells, it is what we will do with the map. To mark our tenth Anniversary month, watch HCA Co-Founder Aviv Regev reveal her hopes for the Human Cell Atlas initiative, and how it is already helping to improve medicine.View quoted post on X
#HumanCellAtlas #Healthcare
A true multidisciplinary scientist, Bowen Li finds that some of the most interesting questions are located precisely at the boundaries between fields nature.com/articles/s4158…
rdcu.be/BiMQqoAu6WLa
rdcu.be/BiMQqoAu6WLa